Lineage Cell Therapeutics, Inc. Common Stock (NY:LCTX)
1.760
+0.060
(+3.53%)
Streaming Delayed Price
Updated: 1:48 PM EDT, Oct 27, 2025
Add to My Watchlist
Headline News about Lineage Cell Therapeutics, Inc. Common Stock
Lineage Cell Revenue Doubles in Q2
August 12, 2025
Via The Motley Fool
Via Benzinga
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
